JPH02250830A - ハート・ビューティ・ドリンク - Google Patents
ハート・ビューティ・ドリンクInfo
- Publication number
- JPH02250830A JPH02250830A JP1073166A JP7316689A JPH02250830A JP H02250830 A JPH02250830 A JP H02250830A JP 1073166 A JP1073166 A JP 1073166A JP 7316689 A JP7316689 A JP 7316689A JP H02250830 A JPH02250830 A JP H02250830A
- Authority
- JP
- Japan
- Prior art keywords
- vitamin
- extract
- drink
- liquid
- food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003796 beauty Effects 0.000 title description 3
- 239000003814 drug Substances 0.000 claims abstract description 26
- 206010036618 Premenstrual syndrome Diseases 0.000 claims abstract description 21
- 229940079593 drug Drugs 0.000 claims abstract description 18
- 235000013305 food Nutrition 0.000 claims abstract description 13
- 235000014214 soft drink Nutrition 0.000 claims abstract description 12
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000007788 liquid Substances 0.000 claims abstract description 9
- 239000000284 extract Substances 0.000 claims abstract description 7
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 6
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 5
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 5
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 5
- 244000124209 Crocus sativus Species 0.000 claims abstract description 3
- 235000015655 Crocus sativus Nutrition 0.000 claims abstract description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 3
- 241001632410 Eleutherococcus senticosus Species 0.000 claims abstract description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 3
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 3
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 3
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims abstract description 3
- 235000011086 calcium lactate Nutrition 0.000 claims abstract description 3
- 229960002401 calcium lactate Drugs 0.000 claims abstract description 3
- 239000001527 calcium lactate Substances 0.000 claims abstract description 3
- 229960002477 riboflavin Drugs 0.000 claims abstract description 3
- 229960003495 thiamine Drugs 0.000 claims abstract description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 3
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 3
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 3
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 3
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract 2
- 229930003268 Vitamin C Natural products 0.000 claims abstract 2
- 235000012907 honey Nutrition 0.000 claims abstract 2
- 229960003080 taurine Drugs 0.000 claims abstract 2
- 235000019154 vitamin C Nutrition 0.000 claims abstract 2
- 239000011718 vitamin C Substances 0.000 claims abstract 2
- 235000005152 nicotinamide Nutrition 0.000 claims description 2
- 239000011570 nicotinamide Substances 0.000 claims description 2
- 235000013974 saffron Nutrition 0.000 claims description 2
- 239000004248 saffron Substances 0.000 claims description 2
- 235000020767 valerian extract Nutrition 0.000 claims description 2
- 235000015701 Artemisia arbuscula Nutrition 0.000 claims 1
- 235000002657 Artemisia tridentata Nutrition 0.000 claims 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims 1
- 240000006891 Artemisia vulgaris Species 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 229960005069 calcium Drugs 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 235000001465 calcium Nutrition 0.000 claims 1
- 239000003651 drinking water Substances 0.000 claims 1
- 235000020188 drinking water Nutrition 0.000 claims 1
- 239000011521 glass Substances 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 230000002175 menstrual effect Effects 0.000 claims 1
- 201000000484 premenstrual tension Diseases 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 231100000957 no side effect Toxicity 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 3
- 239000003963 antioxidant agent Substances 0.000 abstract description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 abstract description 2
- 229960002079 calcium pantothenate Drugs 0.000 abstract description 2
- 235000003599 food sweetener Nutrition 0.000 abstract description 2
- 239000003765 sweetening agent Substances 0.000 abstract description 2
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 abstract 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 abstract 1
- 244000126014 Valeriana officinalis Species 0.000 abstract 1
- 235000013832 Valeriana officinalis Nutrition 0.000 abstract 1
- 230000002421 anti-septic effect Effects 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 235000006708 antioxidants Nutrition 0.000 abstract 1
- 229940064004 antiseptic throat preparations Drugs 0.000 abstract 1
- 239000001209 crocus sativus l. Substances 0.000 abstract 1
- 235000011194 food seasoning agent Nutrition 0.000 abstract 1
- 229940097043 glucuronic acid Drugs 0.000 abstract 1
- 229920001542 oligosaccharide Polymers 0.000 abstract 1
- 150000002482 oligosaccharides Chemical class 0.000 abstract 1
- 239000008213 purified water Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 239000000820 nonprescription drug Substances 0.000 description 3
- -1 coctooligo Chemical compound 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000003821 menstrual periods Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000009247 menarche Effects 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229940127234 oral contraceptive Drugs 0.000 description 1
- 239000003539 oral contraceptive agent Substances 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
Classifications
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
- F16L27/00—Adjustable joints, Joints allowing movement
- F16L27/08—Adjustable joints, Joints allowing movement allowing adjustment or movement only about the axis of one pipe
- F16L27/0804—Adjustable joints, Joints allowing movement allowing adjustment or movement only about the axis of one pipe the fluid passing axially from one joint element to another
- F16L27/0808—Adjustable joints, Joints allowing movement allowing adjustment or movement only about the axis of one pipe the fluid passing axially from one joint element to another the joint elements extending coaxially for some distance from their point of separation
- F16L27/0824—Adjustable joints, Joints allowing movement allowing adjustment or movement only about the axis of one pipe the fluid passing axially from one joint element to another the joint elements extending coaxially for some distance from their point of separation with ball or roller bearings
- F16L27/0828—Adjustable joints, Joints allowing movement allowing adjustment or movement only about the axis of one pipe the fluid passing axially from one joint element to another the joint elements extending coaxially for some distance from their point of separation with ball or roller bearings having radial bearings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
- F16L27/00—Adjustable joints, Joints allowing movement
- F16L27/08—Adjustable joints, Joints allowing movement allowing adjustment or movement only about the axis of one pipe
- F16L27/087—Joints with radial fluid passages
Landscapes
- Engineering & Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Sealing Using Fluids, Sealing Without Contact, And Removal Of Oil (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1073166A JPH02250830A (ja) | 1989-03-25 | 1989-03-25 | ハート・ビューティ・ドリンク |
| DE4019987A DE4019987C2 (de) | 1989-03-25 | 1990-06-22 | Drehdurchführung |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1073166A JPH02250830A (ja) | 1989-03-25 | 1989-03-25 | ハート・ビューティ・ドリンク |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH02250830A true JPH02250830A (ja) | 1990-10-08 |
Family
ID=13510304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1073166A Pending JPH02250830A (ja) | 1989-03-25 | 1989-03-25 | ハート・ビューティ・ドリンク |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPH02250830A (de) |
| DE (1) | DE4019987C2 (de) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998040086A3 (en) * | 1997-03-10 | 1998-11-19 | Riley Fletcher Foundation | Essential oil composition |
| JP2004262922A (ja) * | 2003-02-13 | 2004-09-24 | Ezaki Glico Co Ltd | サイクルサプリメント |
| US7147876B2 (en) | 2001-08-13 | 2006-12-12 | Michael Hargreaves Riley | Compositions for removal of toxins |
| WO2011074519A1 (ja) * | 2009-12-18 | 2011-06-23 | 財団法人東京都医学研究機構 | 加齢性記憶障害の治療用及び予防用医薬組成物 |
| CN104970415A (zh) * | 2015-06-18 | 2015-10-14 | 周长生 | 一种薏仁饮品及其制备方法 |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7422031B2 (en) * | 2004-03-12 | 2008-09-09 | Fsi International, Inc. | Rotary unions, fluid delivery systems, and related methods |
| DE102008012676A1 (de) * | 2008-03-05 | 2009-09-17 | Hunger Maschinen Gmbh | Drehdurchführung |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3957294A (en) * | 1974-06-06 | 1976-05-18 | The United States Of America As Represented By The Secretary Of The Navy | Rotary gas joint |
-
1989
- 1989-03-25 JP JP1073166A patent/JPH02250830A/ja active Pending
-
1990
- 1990-06-22 DE DE4019987A patent/DE4019987C2/de not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998040086A3 (en) * | 1997-03-10 | 1998-11-19 | Riley Fletcher Foundation | Essential oil composition |
| US6280751B1 (en) | 1997-03-10 | 2001-08-28 | Jane Clarissa Fletcher | Essential oil composition |
| US7147876B2 (en) | 2001-08-13 | 2006-12-12 | Michael Hargreaves Riley | Compositions for removal of toxins |
| JP2004262922A (ja) * | 2003-02-13 | 2004-09-24 | Ezaki Glico Co Ltd | サイクルサプリメント |
| WO2011074519A1 (ja) * | 2009-12-18 | 2011-06-23 | 財団法人東京都医学研究機構 | 加齢性記憶障害の治療用及び予防用医薬組成物 |
| CN104970415A (zh) * | 2015-06-18 | 2015-10-14 | 周长生 | 一种薏仁饮品及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| DE4019987A1 (de) | 1991-01-03 |
| DE4019987C2 (de) | 1997-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bledsoe et al. | The reinterpretation of western pharmaceuticals among the Mende of Sierra Leone | |
| TWI583390B (zh) | 富含鞣花單寧之萃取物組成物 | |
| Afolabi | Self Medication, Drug Dependency and Self-Managed Healthcare–A Review‖ | |
| Joshi et al. | Complementary and alternative medicine use in first-time and recurrent kidney stone formers | |
| JPH02250830A (ja) | ハート・ビューティ・ドリンク | |
| Almukainzi et al. | Investigation of the effects of different beverages on the disintegration time of over-the-counter medications in Saudi Arabia | |
| WO2023123528A1 (zh) | 也可作穴位（经络、反射区）增效剂的物质及其用法 | |
| Weiser | Caffeine as analgesic adjuvant | |
| RU2787368C2 (ru) | Депротеинизированный препарат из телячьей крови для применения в предотвращении или лечении болезни периферических артерий (БПА) | |
| Sonnberg | The Complete Pill Guide: Everything You Need to Know about Generic and Brand-Name Prescription Drugs | |
| Cook | Pain Erasers: The Complete Natural Medicine Guide to Safe, Drug-Free Relief | |
| Al-Worafi | Herbal medicines case studies: Part I | |
| is Here | Asian Medical Nutrition | |
| Reader's Digest Association | The Healing Power of Vitamins, Minerals, and Herbs | |
| question Alias | Will bactrim ds get rid of orbital cellutitis | |
| Yadav | Hand book of Clinical Pharmacy | |
| Hutchinson | The Woman's Guide to Managing Migraine: Understanding the Hormone Connection to Find Hope and Wellness | |
| Lefno et al. | Lefno 20 Tablet 10 | |
| Minocha et al. | How to Stop Heartburn: Simple Ways to Heal Heartburn and Acid Reflux | |
| Royer | PRECAUTIONS ON THE PART OF PHYSICIANS TO AVOID INFLUENZA INFECTION | |
| Willard Bartlett | MEDICAL PUBLICATIONS | |
| Kumar et al. | BIOEQUIVALENCE STUDY OF ANTIMIGRAINE DRUG IN HEALTHY ADULT HUMAN SUBJECTS UNDER FED CONDITIONS | |
| MEDALS | SLmmmmLLS | |
| Samani | Study of representative samples of the more commonly used anti-obesity proprietary preparations | |
| DERS | 3ndian hrial (flžllt |